Castle Creek Pharmaceuticals   Report issue

For profit Phase 2 Phase 3
Founded: Bedminster NJ United States (2015)

Organization Overview

First Clinical Trial
2017
NCT03154333
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Castle Creek Pharmaceuticals | Castle Creek Pharmaceuticals, LLC